Source: Breathe 2006; 2: 355
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
P. Van Schil. Is the highest mediastinal lymph node a prognostic factor in stage IIIA N2 NSCLC?. Breathe 2006; 2: 355

Member's Comments

No comment yet.

Related content which might interest you: Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer Source: Eur Respir J 2013; 41: 649-655 Year: 2013 Risk factors for occult mediastinal lymph node involvement in clinical stage I lung cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=163 Year: 2007 Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Central tumor location and presence of occult lymph node metastasis in cT1N0M0 NSCLC Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 The role of PET-CT in mediastinal lymph node staging in NSCLC Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Accuracy of re-mediastinoscopy and fusion PET-CT in the assessment of lymph node (LN) downstaging after induction chemotherapy for N2 non-small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 602s Year: 2006 The management of single metastasis in stage M1b Source: Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC? Year: 2013 Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007 Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018 Year: 2019 Trends in mediastinal nodal staging and its impact on unforeseen N2 and survival in lung cancer Source: Eur Respir J, 57 (4) 2001549; 10.1183/13993003.01549-2020 Year: 2021 Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment Source: Eur Respir J 2009; 33: 1383-1388 Year: 2009 Lymph node micrometastases (LNMM) in lung cancer: in which position are they relevant, and how can they be detected easily? Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 T cell maturation profile in metastatic vs. non-metastatic lymph nodes in NSCLC patients Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Correlation between p53 expression in bronchus biopsies from non-small cell lung cancer cases and mediastinal lymph node invasion demonstrated through mediastinoscopy Source: Eur Respir J 2006; 28: Suppl. 50, 82s Year: 2006 The influence of nodal size on EUS-FNA outcomes for mediastinal staging of NSCLC Source: Annual Congress 2010 - Are needles enough: the value of different approaches Year: 2010 The relation between clinical tumor stage and metastasis according to sixth TNM staging and new revised TNM staging in non-small lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Independent prognostic und predictive value of blood vessel invasion (BVI) in curatively (R0) resected stage II and IIIA non-small cell lung (NSCLC) cancer patients Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 The role of lymph node standard 18-FDG uptake value and lymph node-primary focus SUVmax ratio in mediastinal staging of NSCLC Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010